|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-5-7
|
|
pubmed:abstractText |
Quetiapine was approved in Germany as an atypical antipsychotic for treatment of schizophrenia in 2000, followed by the approval as an antipsychotic for treatment of bipolar mania in 2003. The approval of quetiapine for treatment of bipolar depression is expected. We hypothesized that the psychogeriatric prescription pattern for quetiapine shifts from the psychotic to the affective spectrum.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0885-6230
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2006 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
401-4
|
|
pubmed:meshHeading |
pubmed-meshheading:17096460-Aged,
pubmed-meshheading:17096460-Aged, 80 and over,
pubmed-meshheading:17096460-Antipsychotic Agents,
pubmed-meshheading:17096460-Bipolar Disorder,
pubmed-meshheading:17096460-Dementia,
pubmed-meshheading:17096460-Dibenzothiazepines,
pubmed-meshheading:17096460-Drug Utilization,
pubmed-meshheading:17096460-Female,
pubmed-meshheading:17096460-Germany,
pubmed-meshheading:17096460-Humans,
pubmed-meshheading:17096460-Male,
pubmed-meshheading:17096460-Middle Aged,
pubmed-meshheading:17096460-Mood Disorders,
pubmed-meshheading:17096460-Psychomotor Agitation,
pubmed-meshheading:17096460-Schizophrenia
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006.
|
|
pubmed:affiliation |
Department of Psychiatry, Ruhr-University Bochum, Bochum, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
